'
국내 혈액질환 환자에서 침습성 아스페르길루스증의 구제치료로서 Voriconazole의 효과와 안전성' 의 주제별 논문영향력
| 주제 |
|
|
|---|---|---|
| 동일주제 총논문수 | 논문피인용 총횟수 | 주제별 논문영향력의 평균 |
| 621 | 0 |
0.0% |
주제별 논문영향력
' 국내 혈액질환 환자에서 침습성 아스페르길루스증의 구제치료로서 Voriconazole의 효과와 안전성' 의 참고문헌
-
Voriconazole: in the treatment of invasive aspergillosisDrugs 62 : 2655 ~ 2664 [2002]
-
Voriconazole: a review of its use in the management of invasive fungal infectionsDrugs 67 : 269 ~ 298 [2007]
-
Voriconazole treatment for lesscommon, emerging, or refractory fungal infectionsClin Infect Dis 36 : 1122 ~ 1131 [2003]
-
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomesClin Infect Dis 46 : 201 ~ 211 [2008]
-
Voriconazole in the management of nosocomial invasive fungal infectionsTher Clin Risk Manag 2 : 129 ~ 158 [2006]
-
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trialClin Infect Dis 44 : 2 ~ 12 [2007]
-
Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy정미영 [2003]
-
Salvage therapy for invasive aspergillosis정미란 [2008]
-
Retrospective chart reviews전성연 [2008]
-
National Institute of Allergy and Infectious Diseases Mycoses Study Group. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever염태호 [2002]
-
Keevil BG, Denning DW. Adverse reactions to voriconazole
-
Issues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection백영균 [2006]
-
Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients
-
Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis배성희 [2002]
-
Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus[2002]
-
Infectious Diseases Society of America. Treatment of aspergillosis: clinical practice guidelines of the infectious diseases society of America박영태 [2008]
-
Identifying adverse events caused by medical care: Degree of physician agreement in a retrospective chart review문혜연 [1996]
-
Factors asso-ciated with overall and attributable mortality in invasive aspergillosis김종백 [2008]
-
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis김수영 [2002]
-
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria교육과학기술부 [2008]
-
Caspofungin Salvage Aspergillosis Study Group. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapyStolovitch [2004]
-
AmBiLoad Trial Study Group. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)Nolen-Hoeksema [2007]
-
A method for estimating the probability of adverse drug reactionsLakoff [1981]
-
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancerJenkins [2002]